Fynn Biotechnologies

Fynn Biotechnologies is a China-based biomedical company focused on spatial multi-omics, targeted proteomics, and precision oncology research services. The company appears to operate primarily as a technology and services provider rather than a drug developer, offering integrated solutions for cancer precision medicine and translational research. Publicly available information indicates strengths in spatial transcriptomics, spatial proteomics, Xenium and Visium data analysis, and related bioinformatics workflows. FynnBio has been described as an early adopter of spatial multi-omics platforms in China and has supported academic and translational studies in tumor microenvironment and biomarker research. The company is active and privately held in Jinan, Shandong.